MedTrace Logo

A Study for Sufficient Acarbose Decreased Glucose Excursion in Type 2 Diabetic Patients

NCT03805191 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 900

Last updated 2019-04-12

No results posted yet for this study

Summary

This is a multicentre observational study to investigate the improvement in glucose fluctuation of sufficient acarbose therapy on type 2 diabetes patient with high blood glucose fluctuation

Conditions

Sponsors & Collaborators

  • Bayer

    collaborator INDUSTRY

  • Qilu Hospital of Shandong University

    lead OTHER

Principal Investigators

  • Lin Liao, MD · Qianfoshan Hospital

  • Yuping Zhou, MD · Weihai Municipal Hospital

  • Shuguang Pang, MD · Jinan Central Hospital

  • Fei Wang, MD · Huangdao Branch of Affiliated Hospital of Medical College,Qingdao University

  • Yongjun Jin, MD · Yantai Branch of Affiliated Binzhou Medical College

  • Tianying Xu, MD · People's hospital of Qihe county

  • Guangzhen Zhang, MD · Liaocheng People's Hospital

  • Yunfeng Zhang, MD · Linyi lanshan district diabetes hospital

  • Lin Sun, MD · Jining Medical University

  • Dadong Fei, MD · Zaozhuang Municipal Hospital

  • Guangling Xu, MD · Guanxian people's hospital of liaocheng city

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2020-11-30
Completion
2022-12-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03805191 on ClinicalTrials.gov